Mitochondrial Metabolism in Cancer Prevention and Treatment

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Mitochondria".

Deadline for manuscript submissions: closed (15 October 2021) | Viewed by 542

Special Issue Editor


E-Mail Website
Guest Editor
Department of Pharmacology, Toxicology & Neuroscience, LSU Health Sciences Center, 1501 Kings Highway, Shreveport, LA 71130, USA
Interests: mitochondrial metabolism in cancer prevention and treatment
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

All forms of life share a common indispensable need for energy. The requirement of energy is necessary for an organism not only to survive but also to thrive. The metabolic activities in normal animal cells rely predominately on mitochondrial oxidative phosphorylation for energy generation in the form of ATP. On the contrary, cancer cells predominately rely on glycolysis rather than oxidative phosphorylation. It is long believed that impairment of mitochondrial oxidative phosphorylation is the cause of this glycolytic phenotype observed in cancers. However, studies in cancer metabolism have revealed that mitochondrial function in many cancers is intact. It has also been observed that cancers utilize various forms of metabolism. The various metabolic phenotypes are employed by cancer cells have a common purpose, to balance macromolecular biosynthesis, cellular reducing power, and sufficient ATP production to support rapid proliferation and accompanied survival threat characteristic of these aberrant cells. These metabolic pathways are attractive targets for possible therapeutic interventions and currently, research is underway to meet this end.

Dr. Yunfeng Zhao
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Oxidative phosphorylation
  • ATP
  • Oncology
  • Cancer prevention
  • Cancer therapy
  • Biosynthesis
  • Metabolic reprogramming

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop